These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Interactions of narcotics an their antagonists with human serum esterase. IX: structure-activity relationships of morphinans and morphines. Bamberger MJ; Gero A Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):189-202. PubMed ID: 7224721 [TBL] [Abstract][Full Text] [Related]
7. Opioid-like discriminative stimulus properties of benzomorphans in the pigeon: stereospecificity and differential substitution patterns. Picker MJ; Negus SS; Dykstra LA Life Sci; 1989; 45(18):1637-45. PubMed ID: 2586224 [TBL] [Abstract][Full Text] [Related]
8. Substitution and primary dependence studies in animals. Woods JH; Gmerek DE Drug Alcohol Depend; 1985 Feb; 14(3-4):233-47. PubMed ID: 4039649 [TBL] [Abstract][Full Text] [Related]
9. Analgesics and narcotic antagonists in the benzomorphan and 8-oxamorphinan series. 5. Lambert Y; Daris JP; Monković I; Pircio AW J Med Chem; 1978 May; 21(5):423-7. PubMed ID: 660584 [TBL] [Abstract][Full Text] [Related]
10. Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Hutchinson M; Kosterlitz HW; Leslie FM; Waterfield AA Br J Pharmacol; 1975 Dec; 55(4):541-6. PubMed ID: 2359 [TBL] [Abstract][Full Text] [Related]
11. Bremazocine causes sympatho-inhibition and hypotension in rabbits by activating peripheral kappa-receptors. Ensinger H; Hedler L; Szabo B; Starke K J Cardiovasc Pharmacol; 1986; 8(3):470-5. PubMed ID: 2425160 [TBL] [Abstract][Full Text] [Related]
12. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266. Frey HH Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842 [TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus properties of bremazocine in the rat. Shearman GT; Herz A Neuropharmacology; 1981 Dec; 20(12A):1209-13. PubMed ID: 7322297 [No Abstract] [Full Text] [Related]
14. 5-allyl-9-oxobenzomorphans. 3. Potent narcotic antagonists and analgesics-antagonists in the series of substituted 2',9beta-dihydroxy-6,7-benzomorphans. Saucier M; Daris JP; Lambert Y; Monkovié ; pircio AW J Med Chem; 1977 May; 20(5):676-82. PubMed ID: 16134 [TBL] [Abstract][Full Text] [Related]
15. In vivo evidence for benzomorphan-selective receptors in rats. Gmerek DE; Cowan A J Pharmacol Exp Ther; 1984 Jul; 230(1):110-5. PubMed ID: 6146703 [TBL] [Abstract][Full Text] [Related]
16. Opiate receptor interactions of benzomorphans in rat brain homogenates. Pert CB; Snyder SH; May EL J Pharmacol Exp Ther; 1976 Feb; 196(2):316-22. PubMed ID: 1255479 [TBL] [Abstract][Full Text] [Related]
19. Unexpected antagonism in the rat vas deferens by benzomorphans which are agonists in other pharmacological tests. Gillan MG; Kosterlitz HW; Magnan J Br J Pharmacol; 1981 Jan; 72(1):13-5. PubMed ID: 6261863 [TBL] [Abstract][Full Text] [Related]
20. N-(2-Cyanoethyl) derivatives of meperidine, ketobemidone, and a potent 6,7-benzomorphan. Uwaydah IM; Waddle MK; Rogers ME J Med Chem; 1979 Jul; 22(7):889-90. PubMed ID: 109618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]